Lantheus Holdings, Inc. is 4.4x more valuable than Anbio Biotechnology by market capitalization ($6.67 B vs $1.50 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NNNN | LNTH |
|---|---|---|
| Market cap | $1.50 B | $6.67 B |
| US-listed rank | #2337 | #1193 |
| Revenue (latest FY) | $8.65M | $1.54B |
| Net income (latest FY) | $6.40M | $233.56M |
| Net margin | 74.1% | 15.2% |
| P/E (trailing FY) | 234.2 | 28.6 |
| SEC filings | 40 | 1,079 |
Lantheus Holdings, Inc. is 4.4x more valuable than Anbio Biotechnology by market capitalization ($6.67 B vs $1.50 B).
In their latest fiscal years, Anbio Biotechnology reported $8.65M in revenue while Lantheus Holdings, Inc. reported $1.54B.
Full pages: Anbio Biotechnology and Lantheus Holdings, Inc., or browse the full rankings.